Open AccessPERFECT trial results: Combining neoadjuvant chemoradiotherapy with atezolizumab is feasible in resectable esophageal adenocarcinoma
Author(s) -
Zhang Liyi
Publication year - 2021
Publication title -
thoracic cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.823
H-Index - 28
eISSN - 1759-7714
pISSN - 1759-7706
DOI - 10.1111/1759-7714.13972
Subject(s) - medicine , oncology , esophageal cancer , atezolizumab , radiation therapy , chemoradiotherapy , carboplatin , adenocarcinoma , cancer , taxane , neoadjuvant therapy , chemotherapy , immunotherapy , pembrolizumab , cisplatin , breast cancer